跳至主要内容
临床试验/CTRI/2022/01/039385
CTRI/2022/01/039385尚未招募未知

A study to assess the status of Ojas in the patients of Madhumeha; Type 2 Diabetes mellitus using Ojas Assessment Scale, Immunological Marker IgG and RBC Membrane Proteins.

All India Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Trial Group- Pre-diagnosed subjects of Madhumeha; Type 2 DM (on oral hypoglycemics but not on Insulin therapy) of either gender, in age group 40-60 years with minimum 10 years of diabetic history.
  • Control Group- Non-diabetic healthy subjects in the age group 40-60 years with no history or
  • features of Madhumeha, any autoimmune and metabolic disorders.

排除标准

  • Subjects suffering with Autoimmune disorders.
  • Subjects suffering with Tuberculosis, Cancer, Jaundice.
  • Subjects suffering with Rajyakshma, Shosha, Grahani, Pandu.
  • Subjects on medication for any infective disease.
  • Subjects not willing to participate.

研究者

相似试验